Hervé Ghesquières

23PUBLICATIONS
77CO-AUTHORS
Predictive and prognostic markersModels of care and place of birthCancer therapy (excl. chemotherapy and radiation therapy)Tumour immunologyMedical mycology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (23)

|Sep 27, 2026
SENIOR-IPI: An easily applicable prognostic index for first-line large B-cell lymphomas patients >80 years treated with curative intent.

|Sep 21, 2026
Contemporary Treatment and Survival Outcomes in Mantle Cell Lymphoma: A National Real-World Analysis From REALYSA, a LYSA Cohort.

|Jul 10, 2026
Intensified Rituximab, Methotrexate, Procarbazine, and Cytarabine (R-MPVA) Regimen With Sequential Addition of Etoposide to R-MPV and Ifosfamide to R-AraC for Newly Diagnosed Primary CNS Lymphoma Patients Aged Between 60 and 70 Years: An LOC Network Study.

|Jan 09, 2026
Genome-wide association study of event-free survival in follicular lymphoma patients treated with front-line immunochemotherapy.

Hervé Ghesquières, Youenn Drouet, Susan L Slager

|Apr 16, 2025
Netrin-1 and B-cell maturation antigen expression in a large cohort of 361 lymphomas: sensitive and specific staining in plasmablastic lymphomas, and therapeutic perspectives.

Marie Donzel, Alexis Trecourt, Hervé Ghesquières

|Dec 01, 2024
Safety and Efficacy of Tinostamustine in a Subpopulation of Patients With Relapsed/Refractory Hodgkin Lymphoma From a Phase I Trial.

Anna Sureda, Antonio Pinto, Hervé Ghesquières

Pageof 4

Frequent Collaborators

5 joint publications

Lucie Oberic

2 joint publications

David Sibon

2 joint publications

Pierre Sesques

2 joint publications

Cédric Rossi